不得外传。©2022 年美国国家综合癌症网络版权所有。版本 3.2022 — 2022 年 3 月 16 日NCCN.orgNCCN Guidelines for Patients® 可于网址 www.nccn.org/patients 获取 NCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines®) 文档格式:PDF | 页数:285 | 浏览次数:280 | 上传日期:2023-02-08...
7. NCCN Guideline non-small cell lung cancer V4.2022 8. CSCO 非小细胞肺癌诊疗指南（2023版） ..11. Liu S, et al. Targeting HER2 Aberrations in Non–Small Cell Lung Cancer with Osimertinib. Clin Cancer Res. 2018;24(11):2594-2604. 12. Riudavets M, et al. Targeting HER2 in non-smal...
[7].Oliver ILLNI,et al. 2022 WCLC EP08.02-122 [8].Smith Egbert F et al. 2022 ESMO 985P [9].Lu S, Fang J, Li X, et al. Lancet Respir Med. 2021;9(10):1154-1164. [10].Non-small cell lung cancer. NCCN Guidelines Version 5...
Lung cancer is the most common cause of cancer-related deaths globally. Although smoking-related lung cancers continue to account for the majority of diagnoses, smoking rates have been decreasing for several decades. Lung cancer in individuals who have never smoked (LCINS) is estimated to be the...
[2]. NCCN Guideline non-small cell lung cancer V4.2022 [3]. CSCO 非小细胞肺癌诊疗指南(2023版) [4]. Zheng R, Zhang S, Zeng H, et al.. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent, 2022, 2(1): 1-9. doi: 10.1016/j.jncc.2022.02.002 ...
NCCN Guidelines(R) Insights: Non-small Cell Lung Cancer, Version 2.2023. J Natl Compr Canc Netw. 2023;21(4):340–50. Article PubMed CAS Google Scholar Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, Le Marchand L. Ethnic and racial differences in the smoking-...
2.HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy.2023.WCLC ...
demonstrated that the preoperative staging of lung cancer by the use of FDG-PET/CT can reduce the total number of thoracotomies and the frequency of futile thoracotomies without any effect on overall survival [14]. According to the most recent NCCN guidelines, the use of integrated PET/CT...
To qualify for screening, patients had to meet the NCCN Guidelines high-risk criteria for CTLS, have a physician order for screening, be asymptomatic, be lung cancer-free for 5 years, and have no known metastatic disease. We ... BJ Mckee,S Regis,AK Borondy-Kitts,... - 《J Natl Com...
Accessed September 21, 2022. To view the most recent and complete version of the NCCN Guidelines for Patients, visit NCCN.org/patientguidelines. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer V.5.2022. ©National...